Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026)
Phibro Animal Health (PAHC) recorded quarterly Income from Continuing Operations of 24024000.0 in Q1 2026, down 12.51% quarter-over-quarter from 27459000.0 in Q4 2025, and up 15.06% on a YoY basis from 20880000.0 in Q1 2025.
Phibro Animal Health (PAHC) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Phibro Animal Health's Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 24024000.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 15.06% year-over-year to 24024000.0; the TTM figure through Mar 2026 stood at 25792000.0 (up 1426.75% YoY), while the FY2025 annual figure was 21178000.0, up 32.38% from the prior year.
- Income from Continuing Operations was 24024000.0 for Q1 2026 at Phibro Animal Health, down from 27459000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 27459000.0 in Q4 2025 to a low of 52218000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 1405058.82 across 5 years, with a median of 6975000.0 in 2024.
- The sharpest annual moves came in 2022 and 2025: Income from Continuing Operations sank 1747.96% in 2022, then soared 762.14% in 2025.
- A 5-year view of Income from Continuing Operations shows it stood at 7210000.0 in 2022, then tumbled by 82.33% to 1274000.0 in 2023, then jumped by 150.0% to 3185000.0 in 2024, then soared by 762.14% to 27459000.0 in 2025, then fell by 12.51% to 24024000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 24024000.0 (Q1 2026), 27459000.0 (Q4 2025), and 26527000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | Phibro Animal Health | 1.32 Bn | 1.24 Bn | 125.68 Mn | 24.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 24.02 Mn |
| Dec 31, 2025 | 27.46 Mn |
| Sep 30, 2025 | 26.53 Mn |
| Jun 30, 2025 | -52.22 Mn |
| Mar 31, 2025 | 20.88 Mn |
| Dec 31, 2024 | 3.19 Mn |
| Sep 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | -32.98 Mn |
| Mar 31, 2024 | 8.41 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | -8.02 Mn |
| Jun 30, 2023 | -3.28 Mn |
| Mar 31, 2023 | 10.04 Mn |
| Dec 31, 2022 | 7.21 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | -37.15 Mn |
| Mar 31, 2022 | 17.69 Mn |
| Dec 31, 2021 | 17.47 Mn |
| Sep 30, 2021 | 6.53 Mn |
| Jun 30, 2021 | 2.25 Mn |